WAKO DIRECT LDL-C— 510(k) K982271

Substantially Equivalent

Wako Chemicals USA, Inc.

FDA 510(k) clearance K982271 for WAKO DIRECT LDL-C, Substantially Equivalent on 1998-09-22. Applicant: Wako Chemicals USA, Inc..

Clearance details

Applicant: Wako Chemicals USA, Inc.
Product code: Code MRR
Advisory panel: Clinical Chemistry
Date received: 1998-06-29
Decision date: 1998-09-22
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Richmond, VA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.